REVIEW STUDY ON ANALYSIS OF THE SOLUBILITY OF BIOPHARMACEUTICAL CLASSIFICATION SYSTEM CLASS II DRUGS IN A SELF-EMULSIFYING DRUG DELIVERY SYSTEM

DEVENDRA SINGH LODHI; AAKASH SINGH PANWAR; NIRMAL DONGRE

doi:10.22159/ajpcr.2022.v15i2.43303

Authors

DEVENDRA SINGH LODHI Department of Pharmaceutics, Institute of Pharmaceutical Sciences, SAGE University, Indore, Madhya Pradesh, India
AAKASH SINGH PANWAR Department of Pharmaceutics, Institute of Pharmaceutical Sciences, SAGE University, Indore, Madhya Pradesh, India
NIRMAL DONGRE Department of Pharmaceutics, Institute of Pharmaceutical Sciences, SAGE University, Indore, Madhya Pradesh, India

DOI:

https://doi.org/10.22159/ajpcr.2022.v15i2.43303

Keywords:

Biopharmaceutical classification system Class II, Enhanced solubility, Self-emulsifying drug delivery system, Bioavailability, First Pass Metabolism, Lipid-based formulation

Abstract

By dissolving drug molecules in these solutions, a unit dosage form for oral administration can be generated for oral administration. Self-emulsifying drug delivery system (SEDDS) is utilized to address the inadequate bioavailability of poorly soluble and highly permeable drugs, according to the literature. These methods can disseminate and deliver hydrophobic medications as a unit dose form for oral administration in this fashion. SEDDS formulations self-emulsify (micro/nano) after being discharged into the intestinal lumen and coming into contact with the gastrointestinal (GI) fluid. Several factors must be considered to make the oral drug administration difficult, including poor water solubility and limited permeability. Self-emulsifying drug delivery can increase the solubility of biopharmaceutical classification system (BCS) II medicines. The SEDDS is a drug delivery system that enhances the solubility of lipophilic medications. It has risen in popularity over time. Under moderate agitation and subsequent dilution, GI fluids are categorized as hydrophilic liquid mixes that are isotropic. This research looks at a variety of uses as well as recent advancements in SEDDS composition, evaluation, dosage forms, and novel techniques to convert liquid SEDDS to solids. Final Thoughts Determining whether or not it is feasible to construct a BCS Category 2 medication formulation based on SEDDS represents a significant contribution of this effort. Medicines with solubility issues and low and variable bioavailability will benefit from the connected technologies.

Downloads

Download data is not yet available.

References

Van Staden D, Du Plessis J, Viljoen J. Development of topical/ transdermal self-emulsifying drug delivery systems, not as simple as expected. Sci Pharm 2020;88:17.

Khadke S, Roces CB, Cameron A, Devitt A, Perrie Y. Formulation and manufacturing of lymphatic targeting liposomes using microfluidics. J Control Release 2019;307:211-20.

Churchyard GJ. A short regimen for rifampin-resistant tuberculosis. N Engl J Med 2019;380:1279-80.

Nunn AJ, Phillips PP, Meredith SK, Chiang CY, Conradie F, Dalai D, et al. A trial of a shorter regimen for rifampin-resistant tuberculosis. N Engl J Med 2019;380:1201-13.

Van Zyl L, Viljoen JM, Haynes RK, Aucamp M, Ngwane AH, Du Plessis J. Topical delivery of artemisone, clofazimine and decoquinate encapsulated in vesicles and their in vitro efficacy against Mycobacterium tuberculosis. AAPS PharmSciTech 2019;20:33.

Van Zyl L, Du Plessis J, Viljoen J. Cutaneous tuberculosis overview and current treatment regimens. Tuberculosis 2015;95:629-38.

Bellefroid C, Lechanteur A, Evrard B, Piel G. Lipid gene nanocarriers for the treatment of skin diseases: Current state-of-the-art. Eur J Pharm Biopharm 2019;137:95-111. Chen Q, Chen W, Hao F. Cutaneous tuberculosis: A great imitator. Clin Dermatol 2019;37:192-9.

Rao M, Valentini D, Zumla A, Maeurer M. Evaluation of the efficacy of valproic acid and suberoylanilide hydroxamic acid (vorinostat) in enhancing the effects of first-line tuberculosis drugs against intracellular Mycobacterium tuberculosis. Int J Infect Dis 2018;69:78-84.

Li GL, Xu Z, Jiang Y, Liu HC, Zhao LL, Li MC, et al. Synergistic activities of clofazimine with moxifloxacin or capreomycin against Mycobacterium tuberculosis in China. Int J Antimicrob Agents 2019;54:642-6.

Humberstone AJ, Porter CJ, Charman WN. A physicochemical basis for the effect of food on absolutely the oral bioavailability of halofantrine. J Pharm Sci 1996;85:525-9.

Pouton CW. Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying, and self-micro emulsifying drug delivery systems. Eur J Pharm Sci 2000;11:S93-8.

Charman WN. Lipids, lipophilic drugs, and oral drug delivery some emerging concepts. J Pharm Sci 2000;89:967-8.

Fleisher D, Li C, Zhou Y, Pao LH, Karim A. Drug, meal, and formulation interactions influencing drug absorption after oral administration. Clinical implications. Clin Pharmacokinet 1999;36:233-54.

Tso P. Gastrointestinal digestion and absorption of lipid. Adv Lipid Res 1985;21:143-86.

Dintaman JM, Silverman JA. Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res 1999;16:1550-6.

Trevaskis NL, Charman WN, Porter CJ. Lipid-based delivery systems and intestinal lymphatic drug transport: A mechanistic update. Adv Drug Deliv Rev 2008;60:702-16.

Van Citters GW, Lin HC. The ileal brake: A fifteen-year report. Curr Gastroenterol Rep 1999;1:404-9.

Shaji J, Jadhav D. Newer approaches to self-emulsifying drug delivery system. Int J Pharm Pharm Sci 2010;2:37-42.

Wakerly MG, Pouton CW, Meakin BJ, Morton FS. Self-emulsification of vegetable oil-non-ionic surfactant mixtures. Am Chem Soc Symp Series 1986;311:242-55.

Komuro TR, Gurley B, Khan MA, Reddy IK. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: Formulation development and bioavailability assessment. Int J Pharm 2001;212:233-46.

Charman SA, Charman WN, Rogge MC. Self-emulsifying drug delivery systems: Formulation and evaluation of an investigational lipophilic compound. Pharm Res 1992;9:87-93.

Pouton CW. Formulation of self-emulsifying drug delivery systems. Adv Drug Deliv Rev 1997;25:47-58.

Klauser RM, Irshik H, Kletzmayr J, Sturm I, Brunner W, Woloszczuk W. Pharmacokinetic cyclosporine a profile under long-term neoral treatment in renal transplant recipients: Does fat intake still matter? Transplant Proc 1997;29:3137-40.

Khoo SM, Humberstone AJ, Porter CJ, Edwards GA, Charman WN. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int J Pharm 1998;167:155-64.

Jayaraj AA, Keirns JJ. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J Pharm Sci 1998;87:164-9.

Solomon LJ, Seager H, Pouton CW. Influence of lipolysis on drug absorption from the alimentary canal. Adv Drug Deliv Rev 1997;25:33-46.

Porter CJ, Kaukonen AM, Boyd B, Edwards GA, Charman WN. Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation. Pharm Res 2004;21:1405-12.

Gursay N, Garrigue JS, Razafindratsita A, Lambert G, Benita S. Excipients effects on in vitro cytotoxicity of a unique paclitaxel self-emulsifying drug delivery system. J Pharm Sci 2003;92:12.

de Smidt PC, Campanero MA, Trocóniz IF. Intestinal absorption of penclomedine from lipid vehicles within the conscious rat: Contribution of emulsification vs digestibility. Int J Pharm 2004;270:109-18.

Charman WN, Porter CJ, Mithani S, Dressman JB. Physiochemical and physiological mechanisms for the consequences of food on drug absorption: The role of lipids and pH. J Pharm Sci 1997;86:269-82.

Patel MJ, Patel SS, Patel MN, Patel MM. A self-micro emulsifying drug delivery system (SMEDDS). Int J Pharm Sci Rev Res 2010;3:29-33.

Holm R, Porter CJ, Müllertz A, Kristensen HG, Charman WN. Structured triglyceride vehicles for oral delivery of halofantrine: An examination of intestinal lymphatic transport and bioavailability in conscious rats. Pharm Res 2002;19:1354-61.

Karim A, Gokhale R, Cole M, Sherman J, Yeramian P, Bryant M, Franke H. HIV PI SC-52151: A unique method of optimizing bioavailability profile via a microemulsion drug delivery system. Pharm Res 1994;11:S368.

Yuasa H, Sekiya M, Ozeki S, Watanabe J. Evaluation of milk fat globule membrane (MFGM) emulsion for oral administration: Absorption of a-linolenic acid in rats and therefore the effect of emulsion droplet size. Biol Pharm Bull 1994;17:756-8.

Swenson ES, Milisen WB, Curatolo W. Intestinal permeability enhancement: Efficacy, acute local toxicity, and reversibility. Pharm Res 1994;11:1132-42.

Shah NH, Carvajal MT, Patel CI, Infeld MH, Malick AW. Self-emulsifying drug delivery systems (SEDDS) with polyglycolic glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm 1994;106:15-23.

Levy MY, Benita S. Drug release from submicron-sized o/w emulsion: A replacement in vitro kinetic evaluation model. Int J Pharm 1990;66:29-37.

Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects. Pharm Res 1995;12:1561-72.

Gandhi A, Maji1 P. Self-emulsifying drug delivery system: An approach for enhancement of bioavailability of poorly water-soluble drugs. Int J Pharm Integr Life Sci 2010;15:958-65.

Pallavi M. Self-emulsifying drug delivery system (seeds): A review. Int J Pharm Bio Sci 2012;2:42-52.

Patil P, Paradkar A. Porous polystyrene beads as carriers for self-emulsifying system containing loratadine. AAPS PharmSciTech 2006;7:E1-7.

Yi T, Wan J, Xu H, Yang X. A replacement solid self-micro emulsifying formulation prepared by Spray drying to enhance the oral bioavailability of poorly water-soluble drugs. Eur J Pharm Biopharm 2008;70:439-44.

Yan YD, Kim JA, Kwak MK, Yoo BK, Yong CS, Choi HG. Enhanced oral bioavailability of curcumin via a solid lipid based self-emulsifying drug delivery system using a spray drying technique. Biol Pharm Bull 2011;34:1179-86.

Balkrishan P, Lee BJ, Oh DH, Kim JO, Hong MJ, Jee JP, et al. Enhanced oral bioavailability of dexibuprofen by a unique solid self-emulsifying drug delivery system. Eur J Pharm Biopharm 2009;72:539-45.

Passerini N, Albertini B, Perissutti B, Rodriguez L. Evaluation of melt granulation and ultrasonic Spray congealing techniques to reinforce dissolution of praziquantel. Int J Pharm 2006;318:92-102.

Cavallari C, Rodriguez L, Albertini B, Passerini N, Rosetti F, Fini A. Thermal and fractal analysis of diclofenac/Gelucire 50/13 micro particles obtained by ultrasound-assisted atomization. J Pharm Sci 2005;94:1124-34.

Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G, et al. Development of self‐micro emulsifying drug delivery systems for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 2004;274:65-73.

Patil PR, Chaulang GM, Akolkotkar A, Mutha SS, Hardikar SR, Bhosale AV, et al. Self-emulsifying drug delivery system: A review. Res J Pharm Technol 2008;1:313-23.

Chen Y, Li G, Huang JG, Wang RH, Liu H, Tang R. Comparison of self-micro emulsifying drug delivery system versus solid dispersion technology used in the improvement of dissolution rate and bioavailability of vinpocetine. Acta Pharm Sin 2009;44:658-66.

Taha E, Ghorab D, Zaghloul AA. Bioavailability assessment of Vitamin A self-nanoemulsified drug delivery systems in rats: A comparative study. Med Princ Pract J 2007;16:355-9.

Singh AK, Chaurasiya A, Awasthi A, Mishra G, Asati D, Khar RK, et al. Oral bioavailability enhancement of exemestane from self-micro emulsifying drug delivery system (SMEDDS). AAPS PharmSciTech 2009;10:906-16.

Qi X, Wang L, Zhu J, Hu Z, Zhang J. Self-double-emulsifying drug delivery system (SDEDDS): A replacement way for oral delivery of medicine with high solubility and low permeability. Int J Pharm 2011;409:245-51.

Kyatanwar AU, Jadva KR. Self-micro-emulsifying drug delivery system (SMEDDS): Review. J Pharm Res 2010;3:75-83.

Chen Y, Chen C, Zheng J, Chen Z, Shi Q, Liu H. Development of a solid S-SEDDS of docetaxel with improved dissolution and bioavailability. Biol Pharm Bull 2011;34:278-86.

Mishra N, Srivastava S. New strategy for solubilisation of poorly soluble drug SEDDS. Pharm Lett 2009;1:60-7. Singh B, Khurana L, Bandyopadhyay S, Kapil R, Katare OO. Development of optimized self-Nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential. Drug Deliv 2011;18:599-612.

Serration M, Newton M, Booth S, Clarke A. Controlled drug release from pellets containing water‐insoluble drugs dissolved during a self-emulsifying system. Eur J Pharm Biopharm 2007;65:94-8.

Kawakami K. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs. Adv Drug Deliv Rev 2012;64:480-95.

Mistry R, Sheth NS. Self-emulsifying drug delivery system. Int J Pharm Pharm Sci 2011;3:23-8.

Attama AA, Nzekwe IT, Nnamani PO, Adikwu MU, Onugu CO. The use of solid self-emulsifying system in the delivery of diclofenac. Int J Pharm 2003;262:23-8.

Attama A, Nkemnele MO. In vitro evaluation of drug release from self-emulsifying drug delivery systems using a biodegradable homolipid from Capra hircus. Int J Pharm 2005;304:4-10.

Yunxia H, Chang J, Guo Y, Yuan X, Kang C. Preparation and evaluation of 5-FU/PLGA/gene nanoparticles. Key Eng Mater 2005;288- 289:147-50.

Trickler WJ, Nagvekar AA, Dash AK. A novel nanoparticle formulation for sustained Paclitaxel delivery. AAPS PharmSciTech 2008;9:486-93.

Kawakami K. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs. Adv Drug Deliv Rev 2012;64:480-95.

Patil P, Paradkar A. Porous polystyrene beads as carriers for self-emulsifying system containing loratadine. AAPS PharmSciTech 2006;7:E1-7.

Yi T, Wan J, Xu H, Yang X. A new solid self-micro emulsifying formulation prepared by Spray drying to improve the oral bioavailability of poorly water soluble drugs. Eur J Pharm Biopharm 2008;70:439-44.

Yan YD, Kim JA, Kwak MK, Yoo BK, Yong CS, Choi HG. Enhanced oral bioavailability of curcumin via a solid lipid based self-emulsifying drug delivery system using a spray drying technique. Biol Pharm Bull 2011;34:1179-86.

Balkrishan P, Lee BJ, Oh DH, Kim JO, Hong MJ, Jee JP, et al. Enhanced oral bioavailability of dexibuprofen by a unique solid self-emulsifying drug delivery system. Eur J Pharm Biopharm 2009;72:539-45.

Passerini N, Albertini B, Perissutti B, Rodriguez L. Evaluation of melt granulation and ultrasonic Spray congealing techniques to reinforce dissolution of praziquantel. Int J Pharm 2006;318:92-102.

Cavallari C, Rodriguez L, Albertini B, Passerini N, Rosetti F, Fini A. Thermal and fractal analysis of diclofenac/Gelucire 50/13 micro particles obtained by ultrasound-assisted atomization. J Pharm Sci 2005;94:1124-34.

Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G, et al. Development of self‐micro emulsifying drug delivery systems for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 2004;274:65-73.

Patil PR, Chaulang GM, Akolkotkar A, Mutha SS, Hardikar SR, Bhosale AV. Self-emulsifying drug delivery system: A review. Res J Pharm Technol 2008;1:313-23.

Chen Y, Li G, Huang JG, Wang RH, Liu H, Tang R. Comparison of self-micro emulsifying drug delivery system versus solid dispersion technology used in the improvement of dissolution rate and bioavailability of vinpocetine. Acta Pharm Sin 2009;44:658-66.

Taha E, Ghorab D, Zaghloul AA. Bioavailability assessment of Vitamin A self-nanoemulsified drug delivery systems in rats: A comparative study. Med Princ Pract J 2007;16:355-9.

Singh AK, Chaurasiya A, Awasthi A, Mishra G, Asati D, Khar RK, et al. Oral bioavailability enhancement of exemestane from self-micro emulsifying drug delivery system (SMEDDS). AAPS PharmSciTech 2009;10:906-16.

Vaz S, Silva R, Amaral M, Martins E, Lobo JM, Silva A. Evaluation of the biocompatibility and skin hydration potential of Vitamin E-loaded lipid nanosystems formulations: In vitro and human in vivo studies. Colloids Surfaces B Biointerfaces 2019;179:242-9.

Gore E, Picard C, Savary G. Spreading behavior of cosmetic emulsions: Impact of the oil phase. Biotribology 2018;16:17-24.